Q32 Bio Inc. (QTTB) Operating cash flow 2017–2025
Q32 Bio Inc. (QTTB) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$33.5MFY2025 · since FY2017: $6.5M → -$33.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$33.5M | +50.5% |
| FY2024 | -$67.7M | -262.6% |
| FY2023 | -$18.7M | +83.6% |
| FY2022 | -$113.7M | -3.6% |
| FY2021 | -$109.8M | -16.3% |
| FY2020 | -$94.3M | -3.3% |
| FY2019 | -$91.4M | -114.6% |
| FY2018 | -$42.6M | -756.9% |
| FY2017 | $6.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More QTTB financial trends
QTTB RevenueQTTB Net incomeQTTB Net marginQTTB Gross profitQTTB Gross marginQTTB Operating incomeQTTB Operating marginQTTB Free cash flowQTTB Capital expendituresQTTB Return on equityQTTB Stock buybacksQTTB Dividends paidQTTB Total assetsQTTB Total liabilitiesQTTB Shareholders’ equityQTTB overview →